Wide-Spectrum Nano-Antibiotics Based on TPA-Py@AuNCs⊂BSA for Multimodal Synergistic Therapy of Drug-Resistant Bacteria and Wound Infections
Feng-Rui Xu , Guo-Ling Zhang , Kai Zhang , Pu Chen , Qianqian Wang , Yuezhe Pan , Ben Zhong Tang , Hai-Tao Feng
Aggregate ›› 2025, Vol. 6 ›› Issue (2) : e699
Wide-Spectrum Nano-Antibiotics Based on TPA-Py@AuNCs⊂BSA for Multimodal Synergistic Therapy of Drug-Resistant Bacteria and Wound Infections
To meet the high requirements of biomedical applications in antimicrobial agents, it is crucial to explore efficient nanoantimicrobial agents with no resistance and good biocompatibility for treating infected wounds. In this study, composite nano-antibiotic TPA-Py@AuNCs⊂BSA nanoparticles (TAB NPs) are prepared using hollow mesoporous Au nanocages (AuNCs) loaded with a photosensitizer (namely TPA-Py) with D-π-A structure showing aggregation-induced emission properties. When TPA-Py is encapsulated in the cavity of AuNCs, its fluorescence is suppressed. In the presence of photothermal induction, TPA-Py can be released from the AuNCs, allowing for the restoration of fluorescence illumination and the specific imaging of Grampositive bacteria. TAB NPs demonstrate outstanding antimicrobial activity against a variety of bacteria, and this multimodal antimicrobial property does not lead to the development of bacterial resistance. In vitro experiments show that TAB NPs could eliminate bacteria and ablate bacterial biofilm. In vivo experiments show that the synergistic antimicrobial effect of TAB NPs has a significant positive impact on the treatment of infectedwounds, including rapid antibacterial action, promotion of M2 macrophage polarization, and enhancement of chronic wound healing. This study provides an effective strategy for developing wide-spectrum nano-antibiotics for the ablation of bacterial biofilms and the treatment of infected wounds.
aggregation-induced emission / Au nanocages / bacterial biofilm / multimodal synergistic therapy / nano-antibiotic
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
2024 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |